title: Monitoring Glycemic Control in End-Stage Renal Disease: What Should Be Measured?
authors.affiliation: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Selvin
authors.affiliation: Department of Laboratory Medicine, NIH, Bethesda, MD. sacksdb@mail.nih.gov.
authors.forename: David B
authors.initials: DB
authors.lastname: Sacks
mesh_terms: D001786:Blood Glucose; D017127:Glycation End Products, Advanced; D006801:Humans; D007676:Kidney Failure, Chronic; D006435:Renal Dialysis; D012709:Serum Albumin; D000093423:Glycated Serum Albumin
chemical_list: D001786:Blood Glucose; D017127:Glycation End Products, Advanced; D012709:Serum Albumin; D000093423:Glycated Serum Albumin